ArticleMolecular biology reports2025
The potential role of long non-coding RNAs (HOTAIR and NEAT1) in patients with rheumatoid arthritis.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The HOXA gene cluster: a critical regulator in bone-related disorders.Annals of medicine · 2026Review
- Long non-coding RNA TGFB2-OT1 as a diagnostic biomarker and ceRNA regulator in rheumatoid arthritis.Frontiers in genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease related to multiple environmental, genetic, and epigenetic factors. It affects the articular joints, causing damage to both cartilage and bone. Hox transcript antisense intergenic RNA (HOTAIR) exists on chromosome 12 and regulates chromatin state and epigenetic factors. Nuclear paraspeckle assembly transcript 1 (NEAT1) is located on chromosome 11 and regulates various cellular functions, including inflammation and autoimmunity. This study aimed to investigate the possible role of the long non-coding RNAs (HOTAIR and NEAT1) in RA and their correlations with RA severity. SUBJECTS AND
methodsThis study included 66 participants divided into 2 groups. Group I comprised 33 RA cases and Group II comprised 33 healthy controls of matched age and sex. Laboratory investigations included a complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Diagnosis of RA was confirmed by the measurement of the rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP). The DAS-28 score was used to evaluate the disease activity. Total RNA was extracted from peripheral blood mononuclear cells (PBMNCs) to assess the expression of HOTAIR and NEAT1.
resultsBoth HOTAIR and NEAT1 were significantly upregulated in RA cases compared to the controls (P < 0.001, for each). There were statistically significant positive correlations between HOTAIR and disease duration, DAS-28 score, MHAQ score, RF, and anti-CCP. Additionally, there were statistically significant positive correlations between NEAT1 and disease duration, DAS-28 score, MHAQ score, ESR, CRP, RF, and anti-CCP.
conclusionUpregulated LncRNAs (HOTAIR and NEAT1) may be involved in RA occurrence and may serve as potential biomarkers to assess RA severity.
Indexed as
Identifiers
40875078What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.